Alambic Investment Management, L.P. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$583,000
-55.2%
29,423
-52.3%
0.44%
-45.4%
Q2 2019$1,301,000
-7.1%
61,623
-10.1%
0.80%
+39.8%
Q1 2019$1,401,000
+376.5%
68,564
+364.4%
0.58%
+363.7%
Q4 2018$294,00014,7640.12%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders